CMIC Aiming For Top Five In Global Pharma Contract Business
This article was originally published in PharmAsia News
Executive Summary
CMIC Holdings is aiming to develop a growth strategy that will push it to fifth or sixth position in the global drug contract market, CEO Kazuo Nakamura told reporters at a recent Tokyo press conference.